Wellington, New Zealand – Wellington-based deep tech startup Marama Labs has secured $1.25m in new funding in a round co-led by US-based venture capital firm Quidnet Ventures and New Zealand Growth Capital Partners (NZGCP), with support from several New Zealand investors. Marama Labs’ chemical analysis tools give industrial customers, such as wineries, unique chemical insights […]
We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created […]
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. The funded project aims to make further improvements on HiDef-B8, the company’s flagship product and fully defined medium supplement for human induced pluripotent stem (iPS) cells. First published by the […]
Highlights Trajan Group Holdings Limited raises $90 million in an Initial Public Offering (IPO) Strong investor demand attracting top tier Australian, Asian, UK and NZ institutions 300+ employees participate via employee gift and ESOP, reflecting Trajan’s ‘people first’ culture Listing confirmed for 7th June 2021, 10.30am Melbourne, Australia – Global analytical science and device company […]
LA JOLLA, Calif. — Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the closing of its initial public offering of 11,730,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 1,530,000 additional shares of […]
Capital will enable continued advancement of GenapSys’ electronic-based, next-generation sequencing platform REDWOOD CITY, Calif. — GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM […]
Largest private financing round by an Asia-based life sciences tools company Important milestone in the development of Novo Holdings’ ambitions in Asia As a result of the financing, Amit Kakar, Senior Partner, Head of Novo Holdings Asia will join the company’s Board of Directors Singapore & Copenhagen, Denmark – Novo Holdings today announced that it […]
Largest private fundraising round by an Asia-based life sciences tools company SINGAPORE — Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, […]
Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round. Analytical […]
CAPZA, an independent management company and leading player in private investments in European SMEs – invests in Xenocs, a French deep tech company, through its new Growth Tech strategy. Founded in 2000, Xenocs is a spin-off from the Institut Laue-Langevin (ILL). The company operates on the nanoscale material characterization market through the development and production […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
